By 2020, the worldwide market for biologics is expected to exceed $390 billion (up from $46 billion in 2002) and account for 28% of the global pharmaceutical market. As they are developed across a wider range of therapeutic areas, biosimilars will play a more important role by providing a greater choice of treatment options. A…